<?xml version="1.0"?>
	<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/rss/xsl/60399"?>
<rss xmlns:media="http://search.yahoo.com/mrss" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
<channel>

    <title>Boardroom Radio - ARANA THERAPEUTICS LIMITED (AAH) company webcasts</title>

    <itunes:author>Boardroom Radio</itunes:author>
	<link>http://www.brr.com.au/</link>
	<itunes:subtitle>Putting customers and investors in touch</itunes:subtitle>
	<itunes:summary>Boardroom Radio delivers live and archived audio podcasts of investor presentations from ASX code listed companies to all interested investors</itunes:summary>
	<language>en-us</language>
	<copyright>2008 Boardroom Radio</copyright>
	<itunes:owner>
    	<itunes:name>Boardroom Radio</itunes:name>
    	<itunes:email>info@brr.com.au</itunes:email>
	</itunes:owner>
	<itunes:image>http://www.brr.com.au//images/logo-boardroom-radio-rss.gif</itunes:image>
	<image>
    	<url>http://www.brr.com.au//images/logo-boardroom-radio-rss.gif</url>
    	<title>Boardroom Radio - Audio webcasts of investor presentations from Australian listed companies</title>
    	<link>http://www.brr.com.au/</link>
	</image>
	<itunes:category text="Business">
        <itunes:category text="Investing" />
	</itunes:category>
    
      <item>
		<title>AAH - Arana Announces Key Anti-Inflammatory Drug Milestone - Dr David Fuller, Chief Medical Officer - ARANA THERAPEUTICS LIMITED</title>
        <itunes:author>Dr David Fuller</itunes:author>
		<itunes:summary>AAH - Arana Announces Key Anti-Inflammatory Drug Milestone - Dr David Fuller, Chief Medical Officer</itunes:summary>
		<enclosure url="http://www.brr.com.au/getpodcast/50455/event.mp3" length="" type="audio/mpeg" />
		<guid>http://www.brr.com.au/getpodcast/50455/event.mp3</guid>
		<pubDate>Thu, 28 Aug 2008 06:30:00 GMT</pubDate>
		<itunes:category text="Business"> 
            <itunes:category text="Investing" /> 
			<itunes:category text="Business News" />
		</itunes:category> 
		<itunes:duration>04:40</itunes:duration>
		<itunes:image>http://www.brr.com.au/getimage/id/3596</itunes:image>
		<itunes:keywords>ARANA THERAPEUTICS LIMITED AAH business asx stocks shares</itunes:keywords>
		<event_title>AAH - Arana Announces Key Anti-Inflammatory Drug Milestone - Dr David Fuller, Chief Medical Officer</event_title>
		<event_headline>ART621 Reaches Key Milestone</event_headline>
		<event_company>ARANA THERAPEUTICS LIMITED</event_company>
		<event_presenter>Dr David Fuller</event_presenter>
		<event_url>http://www.brr.com.au/event/50455/art621-reaches-key-milestone</event_url>
    </item>
         <item>
		<title>AAH - 6th Annual Australian Biotechnology Summit 2008, Corporate Overview - Dr John Chiplin, CEO - ARANA THERAPEUTICS LIMITED</title>
        <itunes:author>Dr John Chiplin</itunes:author>
		<itunes:summary>AAH - 6th Annual Australian Biotechnology Summit 2008, Corporate Overview - Dr John Chiplin, CEO</itunes:summary>
		<enclosure url="http://www.brr.com.au/getpodcast/48834/event.mp3" length="" type="audio/mpeg" />
		<guid>http://www.brr.com.au/getpodcast/48834/event.mp3</guid>
		<pubDate>Wed, 06 Aug 2008 05:45:00 GMT</pubDate>
		<itunes:category text="Business"> 
            <itunes:category text="Investing" /> 
			<itunes:category text="Business News" />
		</itunes:category> 
		<itunes:duration>21:54</itunes:duration>
		<itunes:image>http://www.brr.com.au/getimage/id/3281</itunes:image>
		<itunes:keywords>ARANA THERAPEUTICS LIMITED AAH business asx stocks shares</itunes:keywords>
		<event_title>AAH - 6th Annual Australian Biotechnology Summit 2008, Corporate Overview - Dr John Chiplin, CEO</event_title>
				<event_company>ARANA THERAPEUTICS LIMITED</event_company>
		<event_presenter>Dr John Chiplin</event_presenter>
		<event_url>http://www.brr.com.au/event/48834/aah-6th-annual-australian-biotechnology-summit-2008-corporate-overview-dr-john-chiplin-ceo</event_url>
    </item>
             <item>
		<title>AAH - Discussion on the 2008 BIO International Convention in San Diego - Dr Steffen Nock, President Arana Therapeutics Inc  - ARANA THERAPEUTICS LIMITED</title>
        <itunes:author>Dr Steffen Nock</itunes:author>
		<itunes:summary>AAH - Discussion on the 2008 BIO International Convention in San Diego - Dr Steffen Nock, President Arana Therapeutics Inc </itunes:summary>
		<enclosure url="http://www.brr.com.au/getpodcast/47215/event.mp3" length="" type="audio/mpeg" />
		<guid>http://www.brr.com.au/getpodcast/47215/event.mp3</guid>
		<pubDate>Tue, 24 Jun 2008 06:00:00 GMT</pubDate>
		<itunes:category text="Business"> 
            <itunes:category text="Investing" /> 
			<itunes:category text="Business News" />
		</itunes:category> 
		<itunes:duration>10:34</itunes:duration>
		<itunes:image>http://www.brr.com.au/getimage/id/10411</itunes:image>
		<itunes:keywords>ARANA THERAPEUTICS LIMITED AAH business asx stocks shares</itunes:keywords>
		<event_title>AAH - Discussion on the 2008 BIO International Convention in San Diego - Dr Steffen Nock, President Arana Therapeutics Inc </event_title>
				<event_company>ARANA THERAPEUTICS LIMITED</event_company>
		<event_presenter>Dr Steffen Nock</event_presenter>
		<event_url>http://www.brr.com.au/event/47215/aah-discussion-on-the-2008-bio-international-convention-in-san-diego-dr-steffen-nock-president-arana-therapeutics-inc</event_url>
    </item>
         <item>
		<title>AAH - Arana Reports Strong Financial Position  - Dr John Chiplin Managing Director, CEO and Mr Niall Henderson CFO - ARANA THERAPEUTICS LIMITED</title>
        <itunes:author>Dr John Chiplin Managing Director CEO and Mr Nial Henderson CFO</itunes:author>
		<itunes:summary>AAH - Arana Reports Strong Financial Position  - Dr John Chiplin Managing Director, CEO and Mr Niall Henderson CFO</itunes:summary>
		<enclosure url="http://www.brr.com.au/getpodcast/45791/event.mp3" length="" type="audio/mpeg" />
		<guid>http://www.brr.com.au/getpodcast/45791/event.mp3</guid>
		<pubDate>Thu, 22 May 2008 05:30:00 GMT</pubDate>
		<itunes:category text="Business"> 
            <itunes:category text="Investing" /> 
			<itunes:category text="Business News" />
		</itunes:category> 
		<itunes:duration>11:05</itunes:duration>
		<itunes:image>http://www.brr.com.au/getimage/id/5528</itunes:image>
		<itunes:keywords>ARANA THERAPEUTICS LIMITED AAH business asx stocks shares</itunes:keywords>
		<event_title>AAH - Arana Reports Strong Financial Position  - Dr John Chiplin Managing Director, CEO and Mr Niall Henderson CFO</event_title>
				<event_company>ARANA THERAPEUTICS LIMITED</event_company>
		<event_presenter>Dr John Chiplin Managing Director CEO and Mr Nial Henderson CFO</event_presenter>
		<event_url>http://www.brr.com.au/event/45791/aah-arana-reports-strong-financial-position-dr-john-chiplin-managing-director-ceo-and-mr-niall-henderson-cfo</event_url>
    </item>
           <item>
		<title>AAH - Arana and Kyowa Hakko to Co-Develop Anti-Cancer Drug - Dr Cliff Holloway, Vice President of Business Development - ARANA THERAPEUTICS LIMITED</title>
        <itunes:author>Dr Cliff Holloway</itunes:author>
		<itunes:summary>AAH - Arana and Kyowa Hakko to Co-Develop Anti-Cancer Drug - Dr Cliff Holloway, Vice President of Business Development</itunes:summary>
		<enclosure url="http://www.brr.com.au/getpodcast/45114/event.mp3" length="" type="audio/mpeg" />
		<guid>http://www.brr.com.au/getpodcast/45114/event.mp3</guid>
		<pubDate>Mon, 28 Apr 2008 05:35:00 GMT</pubDate>
		<itunes:category text="Business"> 
            <itunes:category text="Investing" /> 
			<itunes:category text="Business News" />
		</itunes:category> 
		<itunes:duration>09:28</itunes:duration>
		<itunes:image>http://www.brr.com.au/getimage/id/4246</itunes:image>
		<itunes:keywords>ARANA THERAPEUTICS LIMITED AAH business asx stocks shares</itunes:keywords>
		<event_title>AAH - Arana and Kyowa Hakko to Co-Develop Anti-Cancer Drug - Dr Cliff Holloway, Vice President of Business Development</event_title>
				<event_company>ARANA THERAPEUTICS LIMITED</event_company>
		<event_presenter>Dr Cliff Holloway</event_presenter>
		<event_url>http://www.brr.com.au/event/45114/aah-arana-and-kyowa-hakko-to-co-develop-anti-cancer-drug-dr-cliff-holloway-vice-president-of-business-development</event_url>
    </item>
         <item>
		<title>Excellence in Biotechnology Investment - Mr John Chiplin, CEO, Arana Therapeutics - ARANA THERAPEUTICS LIMITED</title>
        <itunes:author>Dr John Chiplin</itunes:author>
		<itunes:summary>Excellence in Biotechnology Investment - Mr John Chiplin, CEO, Arana Therapeutics</itunes:summary>
		<enclosure url="http://www.brr.com.au/getpodcast/44986/event.mp3" length="" type="audio/mpeg" />
		<guid>http://www.brr.com.au/getpodcast/44986/event.mp3</guid>
		<pubDate>Wed, 23 Apr 2008 02:15:00 GMT</pubDate>
		<itunes:category text="Business"> 
            <itunes:category text="Investing" /> 
			<itunes:category text="Business News" />
		</itunes:category> 
		<itunes:duration>18:30</itunes:duration>
		<itunes:image>http://www.brr.com.au/getimage/id/3281</itunes:image>
		<itunes:keywords>ARANA THERAPEUTICS LIMITED AAH business asx stocks shares</itunes:keywords>
		<event_title>Excellence in Biotechnology Investment - Mr John Chiplin, CEO, Arana Therapeutics</event_title>
				<event_company>ARANA THERAPEUTICS LIMITED</event_company>
		<event_presenter>Dr John Chiplin</event_presenter>
		<event_url>http://www.brr.com.au/event/44986/excellence-in-biotechnology-investment-mr-john-chiplin-ceo-arana-therapeutics</event_url>
    </item>
         <item>
		<title>AAH - Commencement of Phase II Trials for Lead Compound ART621 - Dr John Chiplin, CEO and Managing Director and Dr David Fuller, Chief Medical Officer - ARANA THERAPEUTICS LIMITED</title>
        <itunes:author>Dr John Chiplin and Dr David Fuller</itunes:author>
		<itunes:summary>AAH - Commencement of Phase II Trials for Lead Compound ART621 - Dr John Chiplin, CEO and Managing Director and Dr David Fuller, Chief Medical Officer</itunes:summary>
		<enclosure url="http://www.brr.com.au/getpodcast/43771/event.mp3" length="" type="audio/mpeg" />
		<guid>http://www.brr.com.au/getpodcast/43771/event.mp3</guid>
		<pubDate>Tue, 18 Mar 2008 04:00:00 GMT</pubDate>
		<itunes:category text="Business"> 
            <itunes:category text="Investing" /> 
			<itunes:category text="Business News" />
		</itunes:category> 
		<itunes:duration>05:48</itunes:duration>
		<itunes:image>http://www.brr.com.au/getimage/id/3898</itunes:image>
		<itunes:keywords>ARANA THERAPEUTICS LIMITED AAH business asx stocks shares</itunes:keywords>
		<event_title>AAH - Commencement of Phase II Trials for Lead Compound ART621 - Dr John Chiplin, CEO and Managing Director and Dr David Fuller, Chief Medical Officer</event_title>
				<event_company>ARANA THERAPEUTICS LIMITED</event_company>
		<event_presenter>Dr John Chiplin and Dr David Fuller</event_presenter>
		<event_url>http://www.brr.com.au/event/43771/aah-commencement-of-phase-ii-trials-for-lead-compound-art621-dr-john-chiplin-ceo-and-managing-director-and-dr-david-fuller-chief-medical-officer</event_url>
    </item>
               <item>
		<title>AAH - Announes Phase II Trials for Lead Compound ART621 - Dr David Fuller, Chief Medical Officer - ARANA THERAPEUTICS LIMITED</title>
        <itunes:author>Dr David Fuller</itunes:author>
		<itunes:summary>AAH - Announes Phase II Trials for Lead Compound ART621 - Dr David Fuller, Chief Medical Officer</itunes:summary>
		<enclosure url="http://www.brr.com.au/getpodcast/37175/event.mp3" length="" type="audio/mpeg" />
		<guid>http://www.brr.com.au/getpodcast/37175/event.mp3</guid>
		<pubDate>Wed, 05 Dec 2007 01:00:00 GMT</pubDate>
		<itunes:category text="Business"> 
            <itunes:category text="Investing" /> 
			<itunes:category text="Business News" />
		</itunes:category> 
		<itunes:duration>06:05</itunes:duration>
		<itunes:image>http://www.brr.com.au/getimage/id/3596</itunes:image>
		<itunes:keywords>ARANA THERAPEUTICS LIMITED AAH business asx stocks shares</itunes:keywords>
		<event_title>AAH - Announes Phase II Trials for Lead Compound ART621 - Dr David Fuller, Chief Medical Officer</event_title>
				<event_company>ARANA THERAPEUTICS LIMITED</event_company>
		<event_presenter>Dr David Fuller</event_presenter>
		<event_url>http://www.brr.com.au/event/37175/aah-announes-phase-ii-trials-for-lead-compound-art621-dr-david-fuller-chief-medical-officer</event_url>
    </item>
         <item>
		<title>AAH - Arana Therapeutics Completes Project With CSL - Dr Rob Crombie, VP Business Development - ARANA THERAPEUTICS LIMITED</title>
        <itunes:author>Dr Rob Crombie</itunes:author>
		<itunes:summary>AAH - Arana Therapeutics Completes Project With CSL - Dr Rob Crombie, VP Business Development</itunes:summary>
		<enclosure url="http://www.brr.com.au/getpodcast/36837/event.mp3" length="" type="audio/mpeg" />
		<guid>http://www.brr.com.au/getpodcast/36837/event.mp3</guid>
		<pubDate>Fri, 30 Nov 2007 01:40:00 GMT</pubDate>
		<itunes:category text="Business"> 
            <itunes:category text="Investing" /> 
			<itunes:category text="Business News" />
		</itunes:category> 
		<itunes:duration>10:38</itunes:duration>
		<itunes:image>http://www.brr.com.au/getimage/id/3560</itunes:image>
		<itunes:keywords>ARANA THERAPEUTICS LIMITED AAH business asx stocks shares</itunes:keywords>
		<event_title>AAH - Arana Therapeutics Completes Project With CSL - Dr Rob Crombie, VP Business Development</event_title>
				<event_company>ARANA THERAPEUTICS LIMITED</event_company>
		<event_presenter>Dr Rob Crombie</event_presenter>
		<event_url>http://www.brr.com.au/event/36837/aah-arana-therapeutics-completes-project-with-csl-dr-rob-crombie-vp-business-development</event_url>
    </item>
           <item>
		<title>AAH - New Direction, New Name, New Future - Dr John Chiplin, CEO - ARANA THERAPEUTICS LIMITED</title>
        <itunes:author>Dr John Chiplin</itunes:author>
		<itunes:summary>AAH - New Direction, New Name, New Future - Dr John Chiplin, CEO</itunes:summary>
		<enclosure url="http://www.brr.com.au/getpodcast/35450/event.mp3" length="" type="audio/mpeg" />
		<guid>http://www.brr.com.au/getpodcast/35450/event.mp3</guid>
		<pubDate>Thu, 08 Nov 2007 01:30:00 GMT</pubDate>
		<itunes:category text="Business"> 
            <itunes:category text="Investing" /> 
			<itunes:category text="Business News" />
		</itunes:category> 
		<itunes:duration>10:36</itunes:duration>
		<itunes:image>http://www.brr.com.au/getimage/id/3281</itunes:image>
		<itunes:keywords>ARANA THERAPEUTICS LIMITED AAH business asx stocks shares</itunes:keywords>
		<event_title>AAH - New Direction, New Name, New Future - Dr John Chiplin, CEO</event_title>
				<event_company>ARANA THERAPEUTICS LIMITED</event_company>
		<event_presenter>Dr John Chiplin</event_presenter>
		<event_url>http://www.brr.com.au/event/35450/aah-new-direction-new-name-new-future-dr-john-chiplin-ceo</event_url>
    </item>
   </channel>
</rss>